Joseph Ciaffoni, President and CEO at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 137,536 shares at $30.40 ($4.2M) on 2023-12-20, disclosed to the SEC on 2023-12-20.
Scheduled sale ($4.2M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.04 | 27,798 | $835K | 20.1% |
| 2 | $30.04 | 27,798 | $835K | 20.1% |
| 3 | $30.03 | 14,516 | $436K | 10.5% |
| 4 | $30.03 | 14,516 | $436K | 10.5% |
| 5 | $30.40 | 26,454 | $804K | 19.4% |
| 6 | $30.40 | 26,454 |
| $804K |
| 19.4% |
| Total | $30.18 avg | 137,536 | $4.2M | 100% |
| Filing → |
| COLL | SELL | 2023-06-01 | $2.7M | — | Filing → |
| COLL | SELL | 2023-02-14 | $302K | — | Filing → |
| COLL | SELL | 2022-12-27 | $58K | — | Filing → |